Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy-Reference-Cited by-同舟云学术

Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy

Published:2003-09 Issue:3 Volume:44 Page:309-314
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kamiya Naoto,Akakura Koichiro,Suzuki Hiroyoshi,Isshiki Shinzou,Komiya Akira,Ueda Takeshi,Ito Haruo

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Circulating neuroendocrine markers in patients with prostate carcinoma;Berruti;Cancer,2000

2. Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate;Angelsen;Prostate,1997

3. Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy in prostate cancer;Isshiki;J Urol,2002

4. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma;Cussenot;J Urol,1996

5. Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer;Lilleby;Prostate,2001

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study;Japanese Journal of Clinical Oncology;2024-02-01

2. Biosensors for prostate cancer detection;Trends in Biotechnology;2023-10

3. Long-term safety and efficacy of enzalutamide for men with castration-resistant prostate cancer: a multicenter, prospective DELC study;2023-08-30

4. Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction;Journal of Personalized Medicine;2023-04-22

5. New generation biomarkers for the detection of prostate cancer;Biosensors and Bioelectronics: X;2022-12